Is a complete ASX/ANR research report available?

No complete published report is available for asx/ANR (ASX/ANR) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

ASX/ANR (ASX/ANR)

Australian Securities Exchange: ASX/ANR · AUD

A$0.01

+0.00 (0.0%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-29 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first ASX/ANR analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	3.2M
Revenue (ttm)	623.8K
Net income (ttm)	-1.3M
EPS (ttm)	-A$0.01
Shares out	316M
Volume	250,000
Beta	0.70

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 623.8K
Net income (ttm): -1.3M
EPS (ttm): -A$0.01
Market cap: 3.2M

All ASX/ANR indicators

Market & fundamental data

Available fields

167

Groups with data

Currency

AUD

Showing 167 of 167 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Australia
Country code	AU
Enterprise value	AUD 2.1M
Exchange	Australian Securities Exchange
Financial currency	AUD
First seen	2026-05-10
Industry	Biotechnology
Industry PE	47.26
Industry PE Fwd	18.52
Isin	AU000000ANR0
Last refreshed	2026-07-29
Market cap	AUD 3.2M
Price	AUD 0.01
Price currency	AUD
Sector	Healthcare
Sector PE	70.01
Sector PE Fwd	25.23
Sic	2836
Symbol	asx/ANR
Website	https://anataralifesciences.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-41.42%
EV/Sales	3.33x
FCF yield	-34.51%
P/B ratio	2.8x
P/S ratio	5.07x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-209.05%
EBITDA Margin	-209%
Gross margin	-37.01%
Gross Profit	AUD -230,830
Net Income	AUD -1.3M
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Pretax Margin	-209.79%
Profit Margin	-209.79%
ROA	-52.81
Roa5y	-62.25
ROCE	-114.6
ROE	-105.2
Roe5y	-133.3
ROIC	-65.55

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-37.96%
Cagr1y	25.02%
Cagr3y	-33.96%
Cagr5y	-40.71%
EPS Growth Quarters	2
EPS Growth Years	3
Revenue Growth	-30.27x
Revenue Growth Q	-66.07x
Revenue Growth Years	1x
Revenue Growth3 Y	100.7x
Revenue Growth5 Y	18.38x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	AUD 0.4
Assets	AUD 1.3M
Cash	AUD 1.1M
Current Assets	AUD 1.3M
Current Liabilities	AUD 188,627
Debt	AUD 0
Equity	AUD 1.1M
Interest Coverage	-124.3
Liabilities	AUD 195,915
Long Term Assets	AUD 0
Long Term Liabilities	AUD 7,288
Net Cash	AUD 1.1M
Net Cash By Market Cap	AUD 34.35
Net Cash Growth	-1.5%
Net Debt Equity	AUD -0.96
Tangible Book Value	AUD 1.1M
Tangible Book Value Per Share	AUD 0
WACC	8.09

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	7.03
Net Working Capital	AUD 52,291
Quick ratio	6.85
Working Capital	AUD 1.1M
Working Capital Turnover	AUD 0.5

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-22.66%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-99.15%
1Y total return	25%
200-day SMA	0.01
3Y total return	-71.21%
50-day SMA	0.01
50-day SMA vs 200-day SMA	50under200
5Y total return	-92.67%
All Time High	1.83
All Time High Change	-99.45%
All Time High Date	2017-11-29
All Time Low	0
All Time Low Change	150%
All Time Low Date	2025-05-12
ATR	0
Beta	0.7
Beta1y	0.96
Beta2y	0.64
Ch YTD	-28.57
High	0.01
High52	0.02
High52 Date	2025-09-10
High52ch	-50%
Low	0.01
Low52	0.01
Low52 Date	2025-07-29
Low52ch	66.67%
Ma50ch	4.17%
Price vs 200-day SMA	-3.85%
RSI	50.81
RSI Monthly	37.8
RSI Weekly	44.17
Sharpe ratio	-0.08x
Sortino ratio	-0.08
Total Return	-22.66%
Tr YTD	-28.57
Tr1w	-9.09%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	AUD -1.3M
Operating margin	-209

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	211,486,333%
Net Borrowing	-7,420
Shares Insiders	16.9%
Shares Institutions	10.36%
Shares Out	315,950,765
Shares Qo Q	13.22%
Shares Yo Y	22.66%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	AUD -1.2M
Adjusted OCF	-1,175,452
Average Volume	771,631.65x
Bv Per Share	0
Ch10y	-99.23
Ch1w	-9.09
Ch1y	25
Ch3y	-72.97
Ch5y	-93.33
Ch6m	-28.57
Change	0%
Change From Open	0
Close	0.01
Days Gap	0
Depreciation Amortization	328
Dollar Volume	2,500
Earnings Date	2026-08-13
EBIT	AUD -1.3M
EBITDA	AUD -1.3M
EPS	AUD -0.01
F Score	3
FCF	AUD -1.1M
FCF EV Yield	-52.57x
FCF Per Share	AUD -0
Financing CF	1,073,899
Fiscal Year End	June
Founded	2,010
Investing CF	50,000
Is Primary Listing	1
Last Earnings Date	2026-02-23
Last Report Date	2025-12-31
Ma150	0.01
Ma150ch	-15.97%
Ma20	0.01
Ma20ch	1.01%
Net CF	33,460
Next Earnings Date	2026-08-13
Open	0.01
Price Date	2026-07-26
Ptbv Ratio	2.8
Relative Volume	0.32x
Revenue	623,759x
SBC By Revenue	13.63x
Share Based Comp	85,013
Tr6m	-28.57%
Volume	250,000
Z Score	-15.48

ASX/ANR (ASX/ANR)

Coverage state: Market snapshot only — no published research

Generate the first ASX/ANR analysis

Price

Financial snapshot

Fair-value bridge

Latest news · ASX/ANR

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ASX/ANR indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on ASX/ANR

Frequently asked questions